![]() ![]() Home/About Us Q&As Other Resources How You Can Help News/Articles Print Documents Contact Us ![]() |
|
|||||||||||
| Current Breast Care Trials at HH | ||||||||||||
![]() |
![]() |
Types of Trials ~ Current Breast Care Trials at Hartford Hospital |
||||||||||
|
Mestastatic Disease Clinical Trials are trials for patients whose cancer has spread beyond the breast and into the lymph nodes under the arm. QUINTILES, INC. / TAIHO Pharmaceutical: A phase II, randomized, double-blinded efficacy and safety study of three doses of TAS-108 administered orally in postmenopausal patients with locally advanced or locally recurrent inoperable or progressive metastatic breast carcinoma following standard first line endocrine therapy. For more information about metastatic disease trials at Hartford Hospital, please contact: Camille A. Servodidio, RN, MPH, CRNO, OCN, CCRP - Program Coordinator, Cancer Clinical Research Office, Cancer Program- Hartford HospitalPhone:(860) 545-5363 Email: cservod@harthosp.org |
||||||||||||
|
Prevention Trials |
||||||||||||
|
|
||||||||||||